AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,685,845 | +84102.1% | 67,046 | -13.4% | 0.30% | -9.4% |
| Q2 2023 | $5,565 | -4.3% | 77,437 | -17.9% | 0.33% | -7.6% |
| Q1 2023 | $5,814 | -19.1% | 94,264 | +1.2% | 0.36% | -19.6% |
| Q4 2022 | $7,188 | -99.8% | 93,190 | -12.6% | 0.44% | +41.9% |
| Q3 2022 | $4,756,000 | +26.1% | 106,582 | +8.2% | 0.31% | +33.8% |
| Q2 2022 | $3,772,000 | -13.3% | 98,490 | -6.3% | 0.23% | +1.3% |
| Q1 2022 | $4,352,000 | +21.2% | 105,137 | +10.6% | 0.23% | +31.2% |
| Q4 2021 | $3,591,000 | +35.8% | 95,047 | +18.5% | 0.18% | +26.6% |
| Q3 2021 | $2,644,000 | -48.6% | 80,211 | +5.2% | 0.14% | -49.3% |
| Q2 2021 | $5,142,000 | +56.1% | 76,227 | +31.0% | 0.27% | +38.4% |
| Q1 2021 | $3,294,000 | – | 58,173 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |